BSE filing, NSE: INDRANIB. Summary written from the filing by ALFA Finder's alert engine.
Indrayani Biotech Ltd: key numbers
- Share price
- ₹7.81
- Market cap
- ₹41.91 Cr
- Revenue (annual)
- ₹137.8 Cr
- Net profit (annual)
- ₹2.16 Cr
- P/E (TTM)
- 20.0×Sector 26.2×
- Promoter holding
- 32.92%-0.34% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indrayani Biotech Ltd
All →Indrayani Biotech Legal & Regulatory
Indrayani Biotech received a tax recovery notice for outstanding demands totaling ₹1.17 Crore for various assessment years, for which the company has filed responses.
- Value
- ₹1.17 Cr
Indrayani Biotech Management Change
Independent Director Mr. K.S. Vaidyanathan has resigned from the Board of Indrayani Biotech Limited, effective October 13, 2026, due to personal reasons.
Indrayani Biotech Other Announcement
Indrayani Biotech Limited submitted the quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Indrayani Biotech Q1 FY27 Results: Net Profit ₹0.5 Cr, Up 150.0% YoY
Indrayani Biotech Ltd reported revenue from operations of ₹37.7 Cr (+29.6% YoY) and net profit of ₹0.5 Cr (+150.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.5 Cr · +150.0% YoY
Indrayani Biotech Merger & Restructuring
Indrayani Biotech sold shares of its subsidiary, Dindigul Farm Product Limited, to the open market. This divestment marks a reduction in the company's subsidiary holding.
Indrayani Biotech Board Meeting Date
Indrayani Biotech will hold a board meeting on October 7, 2026, to consider the company's unaudited financial results for the quarter ended June 30, 2026.
Other capital structure change announcements
All →63 Moons Technologies Capital Structure Change
63SATS, a subsidiary of 63 Moons, signed a warrant subscription deal with BCCL. BCCL pays Rs 6.5 Crore upfront, deferring dilution until warrant exercise.
- Value
- ₹6.50 Cr
63 Moons Technologies Capital Structure Change
Material subsidiary 63SATS Cybertech signed a warrant subscription agreement with Bennett Coleman for 65 warrants. Aggregate warrant value is Rs.65 Crore, with 10% (Rs.6.5 Crore) payable upfront.
- Value
- ₹65.00 Cr
Otco International Capital Structure Change
OTCO International Ltd fixed 06 November 2026 as the record date for consolidating 5 equity shares of Rs.2 face value into 1 share of Rs.10 face value. The consolidation was approved by shareholders at the AGM held 17 September 2026.
Meesho Capital Structure Change
Meesho will invest up to USD 1 lakh in cash, in tranches, in its wholly owned US subsidiary. Its 100% holding stays unchanged, worth about ₹0.01 Crore.
- Value
- ₹0.01 Cr
Man Infraconstruction Capital Structure Change
Man Infraconstruction bought back 40,000 equity shares on October 29, 2026 via Nirmal Bang on NSE at an average ₹111.1898. Cumulative buyback reached 1,03,50,000 shares under the open-market programme.
- Value
- ₹0.44 Cr
Crescentis Capital Capital Structure Change
Crescentis Capital approved Rights Issue terms: 1,02,08,129 shares at ₹78, raising ₹79.62 Crore. Record date November 4; issue closes November 27, 2026.
- Value
- ₹79.62 Cr